3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
124
Precursor Cell Lymphoblastic Leukemia-Lymphoma
76
Leukemia
66
Myelodysplastic Syndromes
56
Lymphoma
34
Lymphoma, Non-Hodgkin
33
Leukemia, Lymphocytic, Chronic, B-Cell
30
Hodgkin Disease
27
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
26
Burkitt Lymphoma
25
Multiple Myeloma
24
Lymphoma, Mantle-Cell
19
Lymphoma, Follicular
18
Hematologic Neoplasms
18
Lymphoma, B-Cell, Marginal Zone
17
Lymphoma, Large B-Cell, Diffuse
16
Leukemia, Biphenotypic, Acute
16
Recurrence
15
Myeloproliferative Disorders
15
Congenital Abnormalities
15
Leukemia, Myelomonocytic, Chronic
13
Anemia, Refractory, with Excess of Blasts
13
Lymphoma, Large-Cell, Immunoblastic
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Blast Crisis
10
Graft vs Host Disease
9
Neoplasms, Plasma Cell
8
Leukemia, Myelomonocytic, Juvenile
8
Primary Myelofibrosis
7
Leukemia, Myelomonocytic, Acute
7
Interventions
Meropenem
3
Ceftazidime
3
Filgrastim
2
Ciprofloxacin
2
Cefepime
2
ceftolozane, tazobactam drug combination
1
Vancomycin
1
Teicoplanin
1
Simvastatin
1
Positron Emission Tomography Computed Tomography
1
Ofloxacin
1
NF protocol
1
Micafungin
1
Metronidazole
1
Levofloxacin
1
Itraconazole
1
Granulocyte Colony-Stimulating Factor
1
Cilastatin, Imipenem Drug Combination
1
Anti-Bacterial Agents
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Febrile Neutropenia
×
Granulocyte Colony-Stimulating Factor
×
Other hematologic neoplasm
×
Clear all
NCT02427919
2015-04-28
DeGREE
Seoul St. Mary's Hospital
Phase 2/3
Unknown
56 enrolled